Shares of HemaCare Co. (OTCMKTS:HEMA – Get Free Report) shot up 0.6% during mid-day trading on Tuesday . The company traded as high as $25.31 and last traded at $25.31. 5,400 shares changed hands during trading, a decline of 86% from the average session volume of 39,950 shares. The stock had previously closed at $25.16.
HemaCare Stock Performance
The stock has a 50-day simple moving average of $25.31 and a 200-day simple moving average of $25.31.
HemaCare Company Profile
HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy.
Featured Stories
- Five stocks we like better than HemaCare
- Learn Technical Analysis Skills to Master the Stock Market
- NVIDIA’s Blackwell Chips Set for Arizona Manufacturing by TSMC?
- How to Invest in Small Cap Stocks
- Okta: Bullish Signals Suggest a Market Reversal Is Underway
- 3 Warren Buffett Stocks to Buy Now
- BlackRock Makes Waves With $12B Private Credit Acquisition
Receive News & Ratings for HemaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HemaCare and related companies with MarketBeat.com's FREE daily email newsletter.
